Purple Biotech earnings were $7.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PPBT earnings report on Dec 31, 2024 announced Q4 2024 earnings of $410.0k, down 38.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PPBT reported annual earnings of $7.2M, with -63.6% growth. The next PPBT earnings date is May 19, 2025.
On PPBT's earnings call on Invalid Date, Purple Biotech (NASDAQ: PPBT) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total PPBT earnings for the quarter were $410.00 thousand. In the same quarter last year, Purple Biotech's earnings per share (EPS) was N/A.
The next PPBT earnings date is Invalid Date. Add PPBT to your watchlist to be reminded of Purple Biotech's next earnings date.
What was PPBT's earnings growth in the past year?
As of Purple Biotech's earnings date in Invalid Date, Purple Biotech's earnings has grown year over year. PPBT earnings in the past year totalled $7.24 million.
Is Purple Biotech profitable or losing money?
As of the last Purple Biotech earnings report, Purple Biotech is currently profitable. Purple Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $7.24 million, a 63.58% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.